Xentuzumab/Exemestane/Everolimus in HR+/HER2- Breast Cancer

Press/Media: Press / Media

Period	Apr 30 2021

Media coverage

Title	Xentuzumab/Exemestane/Everolimus in HR+/HER2- Breast Cancer
Media name/outlet	Breast Cancer Research
Country/Territory	United States
Date	04/30/21
URL	www.medscape.com/viewarticle/947574
Persons	Peter Schmid